Daniel Öhman

806 total citations
14 papers, 302 citations indexed

About

Daniel Öhman is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Epidemiology. According to data from OpenAlex, Daniel Öhman has authored 14 papers receiving a total of 302 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Pulmonary and Respiratory Medicine, 4 papers in Oncology and 4 papers in Epidemiology. Recurrent topics in Daniel Öhman's work include Analytical Chemistry and Chromatography (3 papers), Global Cancer Incidence and Screening (3 papers) and Cervical Cancer and HPV Research (3 papers). Daniel Öhman is often cited by papers focused on Analytical Chemistry and Chromatography (3 papers), Global Cancer Incidence and Screening (3 papers) and Cervical Cancer and HPV Research (3 papers). Daniel Öhman collaborates with scholars based in Sweden, United States and Denmark. Daniel Öhman's co-authors include B. Norlander, T.H. Svensson, Love Linnér, F. Bengtsson, Martin Schalling, K. Miriam Elfström, Björn Carlsson, Sven Törnberg, Finn Bengtsson and Deborah Saraste and has published in prestigious journals such as Journal of Pharmacology and Experimental Therapeutics, PLoS Medicine and Journal of Chromatography A.

In The Last Decade

Daniel Öhman

13 papers receiving 298 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Daniel Öhman Sweden	9	91	79	63	53	46	14	302
Oneeb Majid United Kingdom	14	121 1.3×	43 0.5×	30 0.5×	59 1.1×	17 0.4×	24	550
S. Aubrey Stoch United States	12	90 1.0×	53 0.7×	35 0.6×	102 1.9×	12 0.3×	26	383
Päivi Toivonen Finland	11	40 0.4×	113 1.4×	31 0.5×	89 1.7×	19 0.4×	17	484
Susan Mohamed Italy	10	53 0.6×	57 0.7×	27 0.4×	32 0.6×	5 0.1×	34	395
Guillaume Birraux France	5	95 1.0×	23 0.3×	29 0.5×	183 3.5×	41 0.9×	6	310
Jiro Miyamoto Japan	11	63 0.7×	24 0.3×	19 0.3×	105 2.0×	19 0.4×	30	298
Fleur Gaudette Canada	13	160 1.8×	38 0.5×	9 0.1×	72 1.4×	4 0.1×	29	336
Abhishek G. Sathe United States	7	33 0.4×	37 0.5×	13 0.2×	59 1.1×	14 0.3×	16	190
Tina Hofmaier Austria	6	151 1.7×	12 0.2×	11 0.2×	153 2.9×	12 0.3×	7	332
Nadine Schaefer Germany	13	73 0.8×	11 0.1×	21 0.3×	61 1.2×	8 0.2×	35	416

Countries citing papers authored by Daniel Öhman

Since Specialization

Citations

This map shows the geographic impact of Daniel Öhman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Öhman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Öhman more than expected).

Fields of papers citing papers by Daniel Öhman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Öhman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Öhman. The network helps show where Daniel Öhman may publish in the future.

Co-authorship network of co-authors of Daniel Öhman

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel Öhman. A scholar is included among the top collaborators of Daniel Öhman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel Öhman. Daniel Öhman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Hortlund, Maria, et al.. (2025). Cancer detection using human papillomavirus self‐sampling targeting long‐term non‐attenders in an organized cervical screening program. International Journal of Cancer. 158(10). 2729–2735.

Raja, Anna Axelsson, et al.. (2025). Decreasing aortic diameter and decreasing prevalence of infrarenal aortic aneurysms in a population-based screening programme. British journal of surgery. 112(8). 1 indexed citations

Elfström, K. Miriam, Carina Eklund, Daniel Öhman, et al.. (2021). Organized primary human papillomavirus–based cervical screening: A randomized healthcare policy trial. PLoS Medicine. 18(8). e1003748–e1003748. 17 indexed citations

Hultgren, Rebecka, K. Miriam Elfström, Daniel Öhman, & Anneli Linné. (2020). Long-Term Follow-Up of Men Invited to Participate in a Population-Based Abdominal Aortic Aneurysm Screening Program. Angiology. 71(7). 641–649. 17 indexed citations

Elfström, Miriam, Karin Sundström, Sonia Andersson, et al.. (2019). Increasing participation in cervical screening by targeting long‐term nonattenders: Randomized health services study. International Journal of Cancer. 145(11). 3033–3039. 37 indexed citations

Blom, Johannes, Christian Löwbeer, K. Miriam Elfström, et al.. (2018). Gender-specific cut-offs in colorectal cancer screening with FIT: Increased compliance and equal positivity rate. Journal of Medical Screening. 26(2). 92–97. 33 indexed citations

Linné, Anneli, Rebecka Hultgren, Daniel Öhman, Sven Törnberg, & K. Miriam Elfström. (2018). Abdominal aortic aneurysm screening attendance: Effect of removing the examination fee. Journal of Medical Screening. 25(4). 223–224. 1 indexed citations

Henriksson, Roger, et al.. (2017). [Register for new drugs in cancer care provides a picture of how the drugs are used in the daily clinical practice].. PubMed. 114. 1 indexed citations

Saraste, Deborah, et al.. (2017). Initial participation as a predictor for continuous participation in population-based colorectal cancer screening. Journal of Medical Screening. 25(3). 126–133. 13 indexed citations

10.

Olsson, Anders, et al.. (2010). The use of human plasma as matrix for calibration standards in pre-clinical LC–MS/MS methods—A way to reduce animal use. Journal of Pharmaceutical and Biomedical Analysis. 54(4). 826–829. 8 indexed citations

11.

Öhman, Daniel, et al.. (2003). Determination of Serum Reboxetine Enantiomers in Patients on Chronic Medication With Racemic Reboxetine. Therapeutic Drug Monitoring. 25(2). 174–182. 18 indexed citations

12.

Öhman, Daniel, B. Norlander, Curt Peterson, & Finn Bengtsson. (2002). Simultaneous determination of reboxetine and O-desethylreboxetine enantiomers using enantioselective reversed-phase high-performance liquid chromatography. Journal of Chromatography A. 947(2). 247–254. 23 indexed citations

13.

Öhman, Daniel, Björn Carlsson, & B. Norlander. (2001). On-line extraction using an alkyl-diol silica precolumn for racemic citalopram and its metabolites in plasma. Journal of Chromatography B Biomedical Sciences and Applications. 753(2). 365–373. 31 indexed citations

14.

Linnér, Love, et al.. (2001). Reboxetine Modulates the Firing Pattern of Dopamine Cells in the Ventral Tegmental Area and Selectively Increases Dopamine Availability in the Prefrontal Cortex. Journal of Pharmacology and Experimental Therapeutics. 297(2). 540–546. 102 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact